HIPPO HOLDINGS INC (HIPO)
US4335392027 - Common Stock
HIPO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 141 industry peers in the Insurance industry. The financial health of HIPO is average, but there are quite some concerns on its profitability. HIPO shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
HIPO had negative earnings in the past year.
HIPO had a negative operating cash flow in the past year.
In the past 5 years HIPO always reported negative net income.
HIPO had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of HIPO (-17.91%) is worse than 93.57% of its industry peers.
HIPO's Return On Equity of -72.24% is on the low side compared to the rest of the industry. HIPO is outperformed by 92.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.91% | ||
| ROE | -72.24% | ||
| ROIC | N/A |
ROA(3y)-20.59%
ROA(5y)-24.99%
ROE(3y)-57.33%
ROE(5y)-68.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for HIPO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HIPO has been increased compared to 1 year ago.
There is no outstanding debt for HIPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of -1.30, we must say that HIPO is in the distress zone and has some risk of bankruptcy.
HIPO has a Altman-Z score of -1.30. This is in the better half of the industry: HIPO outperforms 67.86% of its industry peers.
There is no outstanding debt for HIPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.3 |
ROIC/WACCN/A
WACC9.09%
2.3 Liquidity
A Current Ratio of 1.36 indicates that HIPO should not have too much problems paying its short term obligations.
HIPO has a Current ratio of 1.36. This is amongst the best in the industry. HIPO outperforms 87.14% of its industry peers.
HIPO has a Quick Ratio of 1.36. This is a normal value and indicates that HIPO is financially healthy and should not expect problems in meeting its short term obligations.
HIPO's Quick ratio of 1.36 is amongst the best of the industry. HIPO outperforms 87.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.36 |
3. Growth
3.1 Past
HIPO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.89%, which is quite impressive.
HIPO shows a strong growth in Revenue. In the last year, the Revenue has grown by 75.19%.
HIPO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 59.58% yearly.
EPS 1Y (TTM)20.89%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q36.86%
Revenue 1Y (TTM)75.19%
Revenue growth 3Y59.58%
Revenue growth 5YN/A
Revenue growth Q2Q80.17%
3.2 Future
Based on estimates for the next years, HIPO will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.59% on average per year.
HIPO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.63% yearly.
EPS Next Y66.48%
EPS Next 2Y36.39%
EPS Next 3Y23.45%
EPS Next 5Y17.59%
Revenue Next Year78.18%
Revenue Next 2Y51.77%
Revenue Next 3Y41.08%
Revenue Next 5Y31.63%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
HIPO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HIPO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
HIPO's earnings are expected to grow with 23.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.39%
EPS Next 3Y23.45%
5. Dividend
5.1 Amount
HIPO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HIPPO HOLDINGS INC
NYSE:HIPO (5/10/2024, 7:04:00 PM)
After market: 17.98 0 (0%)17.98
-0.54 (-2.92%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap439.07M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.91% | ||
| ROE | -72.24% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.36 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)20.89%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y66.48%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)75.19%
Revenue growth 3Y59.58%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y